PRF Hair Treatment In Weston, FL
Injectable PRF is your own blood, prepared with no anticoagulant and a single low-speed spin, then injected into thinning scalp. The research behind it is real, recent, and smaller than most clinic pages let on. Three published studies carry most of the evidence for PRF in hair. The largest enrolled 74 women. All 3 were built around hair count and density rather than hair thickness. You get those numbers and their limits on this page, before you book anything.
PRF works on scalp that still has follicles in it. It is not a substitute for a transplant, and it is not a diagnosis.
In-person and telehealth appointments available
What injectable PRF is
PRF is a platelet concentrate made from a sample of your own blood, with nothing added to it.
The draw goes into a plain tube. A 2026 paper in Frontiers in Pharmacology describes the preparation as one-step soft-spin centrifugation of whole blood, with no chemical additives and no anticoagulant. The slow spin is the point. It leaves the platelets held inside a fibrin network rather than floating loose in liquid. Injected, that network forms a three-dimensional platelet-rich fibrin scaffold in the tissue, and the same paper reports a slow continuous release of growth factors for up to 10 days after reinjection.
Nothing enters you that did not leave you 20 minutes earlier.
That is the mechanical case for PRF, and it is a reasonable one. It is also not a clinical result, which is why the rest of this page is about the trials rather than the biology.
How to confirm you are actually getting PRF. The term gets used loosely on clinic websites. Three questions settle it:
- Does the collection tube contain an anticoagulant? Real PRF uses none.
- What speed and duration is the spin?
- Is the product injected into the scalp, or applied to the surface of it?
Any provider who does this routinely answers all 3 without looking anything up.
What the published research shows, and what it does not
Three papers carry the weight. Read together they support something narrower and more useful than the marketing version.
The largest trial
A prospective multicenter randomized clinical trial published in the Journal of Dermatological Treatment on April 27, 2026 studied women with female pattern hair loss. Patients were randomly assigned to 4 treatment sessions, spaced monthly, across 3 autologous platelet preparations. The primary outcome was change in target area hair count at 24 weeks.
74 participants completed the protocol. In the injectable PRF group, target area hair count rose 26.54%, with a standard deviation of 11.46. The PRF group recorded the lowest rate of adverse events of the 3 preparations studied. The authors also found that VEGF concentration in the preparation correlated with the size of the hair count increase, which is the closest thing in this literature to a measurable explanation for why some patients respond and others do not.
That is the largest and best-designed piece of evidence PRF has in hair. It is 1 trial, in women, at 1 endpoint, over 24 weeks.
The two smaller studies
The Archives of Dermatological Research study, published February 26, 2025, was a prospective single-center study of 30 patients with androgenetic alopecia who had already responded inadequately to conventional treatment. They received 6 monthly i-PRF injections. At 6 months the authors reported an 80% response rate, with improvement in hair scoring, scalp inflammation scoring, dermatology quality of life index, and patient satisfaction, alongside minimal adverse reactions.
The Journal of Cosmetic and Laser Therapy case series, published July 11, 2024, followed 11 women through 3 injection sessions. Follicular unit density went from 0.57 follicles per square millimetre at baseline to 0.89 at week 12 and 1.03 at week 24. Every hair pull test was negative at both follow-ups, down from a baseline mean of 4.2 hairs pulled. Adverse effects were minor: injection pain lasting seconds, 2 mild transient headaches, and bruising and swelling that cleared in 2 to 4 days.
What these trials measured, and what they did not
The endpoints were hair count and follicular density in a marked target area. Shaft diameter appeared as a secondary measure, not as the question the studies were built to answer.
That gap is worth holding onto, because “thicker hair” is the phrase almost every clinic page uses, and thickness and density are 2 different measurements. More hairs in a marked square centimetre is not the same finding as thicker individual strands. What this research supports is the first 1.
How close is your situation to the people in these studies
The studies did not enroll everyone. Comparing yourself against who they did enroll is a sharper filter than any general list of who makes “a good candidate,” and you can check it yourself against the published papers.
Four things to compare.
1. Is it pattern hair loss? All 3 papers studied androgenetic alopecia or female pattern hair loss. None studied shedding from illness, thyroid disease, iron deficiency, postpartum change, or scarring alopecia. If the cause of your thinning has not been established, that comes first, and the hair restoration workup is where it happens.
2. How advanced is it? The 2024 case series enrolled women at Ludwig stage I and II, which is early to moderate thinning. No trial cited here enrolled advanced loss. Scalp with no visible follicular openings is not what any of this research tested.
3. Have you already tried standard treatment? The 2025 Archives study specifically enrolled people who had responded inadequately to conventional treatment. That is a real and useful population to belong to, and it is a different question from using PRF instead of standard treatment.
4. Are you a woman? The published PRF hair evidence leans female. The 2026 multicenter trial enrolled women with female pattern hair loss. The 2024 case series enrolled 11 women. The 2025 study reported 30 patients with androgenetic alopecia without a sex breakdown in its abstract. Men are not excluded from treatment by any of this, but a man is relying on thinner evidence than a woman is, and you should hear that before you book rather than after.
When PRF is not the answer
Four situations where we would tell you so.
- Scalp with no follicular openings. PRF acts on follicles that are present. It does not create new ones. No study cited here tested it on advanced loss, and a smooth scalp is a surgical conversation rather than an injection one.
- An unidentified or untreated cause. Every trial on this page enrolled diagnosed pattern hair loss. If a thyroid problem, an iron deficiency, a medication, or a recent rapid weight change is driving your shedding, growth factors do not settle that argument. Find the cause first.
- A plan that stops at one session. The published protocols ran 3, 4, and 6 sessions. No trial measured a single injection. One session is a sample, not a course.
- An expectation set by transplant results. What these trials measured was hair count and density in a marked area over 24 weeks. That is a different order of change from a graft procedure, and the two should not be judged against the same photograph.
What to ask before you book PRF anywhere
Take this list to any clinic, including ours.
- Is there an anticoagulant in the tube, and what is the spin protocol?
- Is the product injected into the scalp, or applied to the surface?
- How many sessions, at what interval, and what happens after the course ends?
- Who performs the injection, and what is their credential?
- How will change be measured, and do I get those measurements?
- What happens if nothing changes?
A clinic that cannot answer the first two is not the right place to have this done.
Real Patient Results
Microneedling + PRF + Exosomes — After 2 Sessions
Results vary by individual and treatment plan
Frequently Asked Questions
How many sessions did the studies use?
Three different protocols. The 2026 multicenter trial used 4 sessions spaced monthly. The 2025 Archives of Dermatological Research study used 6 monthly injections. The 2024 case series in the Journal of Cosmetic and Laser Therapy used 3 sessions. Your provider sets a course at consultation; those are the intervals the published work used.
When would I see a change?
The trials measured at 12 and 24 weeks. The 2024 case series recorded a density improvement at week 12 and a larger 1 at week 24. Nothing in the published work supports expecting visible change in the first few weeks.
How strong is the evidence, really?
Promising and thin. One multicenter randomized trial with 74 completers, one single-center study of 30 patients, and one case series of 11 women with no control group. The longest follow-up published is 6 months. That is enough to take PRF seriously and not enough to call it proven.
Does it hurt?
The 2024 case series reported sharp injection pain lasting seconds in every participant, described as tolerable, plus mild transient headache in 2 of 11, and bruising and swelling that resolved within 2 to 4 days.
Do I stop minoxidil or finasteride if I start PRF?
Nothing in the studies on this page tested PRF as a replacement for either drug, and one of them specifically enrolled people who had already been on conventional treatment. Bring your current regimen to the consultation and it gets reviewed as part of the plan rather than discarded.
Will my hair be thicker?
The primary endpoints in this research were hair count and follicular density, not shaft diameter. What the studies support is more hairs in the treated area. Anyone promising thicker individual strands is describing a measurement these trials were not built around.
Can PRF be combined with microneedling?
It can, and the two are frequently paired. Know which route you are getting: the research on this page used injected PRF, not PRF applied over microneedling channels. Both are offered, and they are not interchangeable.
Book a PRF consultation in Weston
A consultation is where the decision gets made, not before it. You get an assessment of whether PRF fits what is actually happening on your scalp, and a straight answer if it does not.
